FDA Recalls Blood Pressure Drugs Over Presence Of Carcinogens.

reported that three drug companies have recalled 126 lots of blood pressure drugs, or angiotensis receptor blockers (ARBs), valsartan and losartan this week, after discovering trace amounts of probable carcinogens in them. According to the recall on the Food and Drug Administration’s website. AurobindoPharma USA reportedly identified small amounts of N-nitrosodiethylamine (NDEA) in their valsartan drugs. Meanwhile, Camber Pharmaceuticals Inc. “recalled 87 lots of losartan that contained small amounts of N-Nitroso N-Methyl 4-amino butyric acid, or NMBA.” Camber “says the active drug ingredient was made at Hetero Labs Limited in India, one of two overseas drug factories linked to repeated blood medication recalls since last July.” MacLeods Pharmaceuticals Limited had recalled a lot of losartan earlier in the week. https://www.usatoday.com/story/money/2019/03/01/losartan-recall-2019-87-lots-recalled-over-potential-carcinogen/3024360002/